Case Report
Copyright ©The Author(s) 2021.
World J Clin Cases. May 16, 2021; 9(14): 3449-3457
Published online May 16, 2021. doi: 10.12998/wjcc.v9.i14.3449
Table 1 Published reports of pure endometrial large cell neuroendocrine carcinoma
Case
Ref.
Age in yr
Presenting symptom
Histology
Immunoprofile positivity
FIGO stage
Surgery
Treatment
Outcome
1Nguyen et al[9]70PMBPure LCNECSynaptophysin, chromogranin A, CD56, EMAIVBTAH, BSO, OMTEtoposide, cisplatinNED 6 mo
2Nguyen et al[9]71PMBPure LCNECSynaptophysin, chromogranin A, CD56, P53, P16,PRIVBTAH, BSO, LND, OMTEtoposide, cisplatin, octreotideDOD 1 mo
3Nguyen et al[9]52PMBPure LCNECNSE, synaptophysinICTAH, BSOEtoposide, cisplatinDOD 7 mo
4Kobayashi et al[10]52Abdominal painPure LCNECSynaptophysin, chromogranin A, CD56IIICTAH, BSO, LNDIrinotecan, cisplatin, RTDOD 10 mo
5Makihara et al[28]73Abdominal distensionPure LCNECSynaptophysin, chromogranin A, NSE, P53IVBRefused surgeryRefused chemotherapyDOD 5 wk
6Makihara et al[28]73PMBPure LCNECSynaptophysin, chromogranin A, CD56, P53IIICTAH, BSO, LND, OMTCisplatin, irinotecanRecurrence at 6 mo
7Ogura et al[29]52MenorrhagiaPure LCNECSynaptophysin, CD56, Ki67IIICNoneNoneDOD 1 mo
8Mulvany et al[27]50PMBPure LCNECNSE, synaptophysinIIICTAH, BSO, LND, OMTCarboplatin, etoposide, RTAWD 12 mo
9Tu et al[15]51PMBPure LCNECCK, P53, CD56, synaptophysinIVBTAH, BSO, OMT, suboptimal debulkingCisplatin, etoposideDOD 3 mo
10Shahabi et al[3]59PMBPure LCNECNSE, chromogranin A, synaptophysin, CD56IIICTAH, BSO, LND, OMT, suboptimal debulkingCarboplatin, paclitaxel, doxorubicin, etoposide, cisplatin, octreotideDOD 12 mo
11Suh et al[22]61Abdominal pain and rapid uterine enlargementPure LCNECsynaptophysin, CD56IIIBTAH, BSO, OMTEtoposide/cisplatin, irinotecan/cisplatin, fluorouracil, leucovorin, irinotecan, RTDOD 23 mo
12Present case73PMBPure LCNECCytokeratin AE1/AE3, chromogranin A, synaptophysin, CD56, P16IIICTAH, BSOPaclitaxel, liposome, carboplatinNED 15 mo